Fresh platinum complexes with promising antitumor activity.
Explore this paper's citation graph
Summary
It can be concluded that structural modifications could substantially modulate the DNA binding mode and DNA damage process, and as a result largely improve the antitumor efficacy of platinum complexes.
- Type
- review
- Published
- 2010-05-31
- Cited by
- 72
- References
- 0
- OpenAlex
- https://openalex.org/W2075010434
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23336938
Keywords
Cisplatin, Platinum, Oxaliplatin, Platinum compounds, Chemistry
References
No references recorded for this paper.
Cited by
- Affinity of a mononuclear monofunctional anticancer Pt(II) complex to human serum albumin: a spectroscopic approach
- Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding (N), (N,O)- or (C,N)- of (1S,2R)[(η5-C5H5)Fe(η5-C5H4)CHNCH(Me)CH(OH)C6H5] and the arrangement of the auxiliary ligands.
- Discovery Analysis of TCGA Data Reveals Association between Germline Genotype and Survival in Ovarian Cancer Patients
- Polyethyleneimine anchored copper(II) complexes: synthesis, characterization, in vitro DNA binding studies and cytotoxicity studies.
- Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
- Biological evaluation of transdichloridoplatinum(II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin
- trans-Dichloro(η 2-ethylene) (N-3-pyridinylmethanesulfonamide)platinum(II). Crystal structure, spectroscopic, and thermoanalytical characterization, and cytotoxicity assays
- Exploring binding affinity of oxaliplatin and carboplatin, to nucleoprotein structure of chromatin: spectroscopic study and histone proteins as a target.
- A mitochondrion-targeting copper complex exhibits potent cytotoxicity against cisplatin-resistant tumor cells through multiple mechanisms of action
- Targeting and delivery of platinum-based anticancer drugs.
- DNA compaction by mononuclear platinum cancer drug cisplatin and the trisplatinum anticancer agent BBR3464: Differences and similarities.
- Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural Factor
- Monofunctional platinum complexes containing a 4-nitrobenzo-2-oxa-1,3-diazole fluorophore: distribution in tumour cells.
- Cu(Nor)2·5H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell cultures
- Noncovalent interactions between a trinuclear monofunctional platinum complex and human serum albumin.
- Noble metals in medicine: Latest advances
- A monofunctional trinuclear platinum complex with steric hindrance demonstrates strong cytotoxicity against tumor cells.
- Dinuclear bridged biphosphinic and mononuclear cyclopalladated complexes of benzylamines: Synthesis, structural characterization and antitumor activity
- trans-thionate derivatives of Pt(II) and Pd(II) with water-soluble phosphane PTA and DAPTA ligands: antiproliferative activity against human ovarian cancer cell lines.
- Cytotoxic palladium(II) complexes of 8-aminoquinoline derivatives and the interaction with human serum albumin.
Related papers
- Cisplatin is more mutagenic than carboplatin or oxaliplatin at equitoxic concentrations
- The application of platinum drugs in the treatment of cancer
- Systemic Evaluation on the Pharmacokinetics of Platinum-Based Anticancer Drugs From Animal to Cell Level: Based on Total Platinum and Intact Drugs
- Stenting versus Medical Treatment for Severe Symptomatic Intracranial Stenosis
- Platinum-based agents for individualized cancer treatment.
- Ministers may legislate after finding 85% of labels on alcohol to be inadequate
- Advancements in the Use of Platinum Complexes as Anticancer Agents.
- Current Status for Oral Platinum (IV) Anticancer Drug Development